home / stock / vir / vir articles

VIR Articles, Vir Biotechnology Inc. - From 06/05/24

Stock Information
Company Name: Vir Biotechnology Inc.
Stock Symbol: VIR
Market: NYSE
Website: vir.bio
Menu
VIR VIR Quote VIR Short VIR News VIR Articles VIR Message Board
Get VIR Alerts

News, Short Squeeze, Breakout and More Instantly...
Why Is Infectious Disease-Focused Vir Biotechnology Stock Trading Higher On Wednesday? | Benzinga

On Wednesday, Vir Biotechnology Inc (NASDAQ:VIR) announced new preliminary data from its Phase 2 SOLSTICE hepatitis delta clinical trial evaluating...
Why Lands' End Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session | Benzinga

Shares of Lands’ End, Inc. (NASDAQ:LE) fell sharply during Wednesday's session following first-quarter results. Lands’ End reporte...

Ollie's Bargain Outlet Posts Upbeat Earnings, Joins Verint Systems, Guidewire Software And Other Big Stocks Moving Higher On Wednesday | Benzinga

U.S. stocks were mixed, with the Dow Jones index falling more than 100 points on Wednesday. Shares of Ollie’s Bargain Outlet Holdings, Inc. (...

Why MercadoLibre Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session | Benzinga

Shares of MercadoLibre, Inc. (NASDAQ: MELI) fell sharply during Friday’s session after the company reported fourth-quarter financial results...
Carvana Posts Q4 Results, Joins LegalZoom.com, Comfort Systems And Other Big Stocks Moving Higher On Friday | Benzinga

U.S. stocks were mostly higher, with the Dow Jones index gaining more than 100 points on Friday. Shares of Carvana Co. (NYSE: CVNA) rose sharply d...

COVAX Global Initiative For COVID-19 Vaccines Comes To An End Amid Shift To Regular Programs | Benzinga

COVAX, the multilateral mechanism for equitable global access to COVID-19 vaccines launched in 2020, will close on 31 December 2023. ...

Vir Biotechnology to Participate in the H.C. Wainwright 4th Annual Hepatitis B Virus (HBV) Conference | Benzinga

SAN FRANCISCO, Oct. 12, 2023 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (NASDAQ:VIR) today announced that Phil Pang, M.D., Ph.D., Vir's Ex...
Vir Biotechnology Announces Multiple Abstracts Highlighting New Chronic Hepatitis B and Hepatitis Delta Data Accepted for Presentation at AASLD's The Liver Meeting® 2023 | Benzinga

SAN FRANCISCO, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (NASDAQ:VIR) today announced that eight abstracts highlighting new data...

Vir Biotechnology to Provide Business Update and Report Third Quarter 2023 Financial Results on November 2, 2023 | Benzinga

SAN FRANCISCO, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (NASDAQ:VIR) today announced the Company will provide a corporate updat...

Biden's Urgent Action Against Antibiotic-Resistant Bacteria - Allocates $100M to Battle Deadly Superbugs | Benzinga

U.S. President Joe Biden is set to unveil a $100 million research initiative to tackle the growing threat of drug-resistant bacteria.&nbs...
Previous 10 Next 10